Skip to main content

Lipideverlagende geneesmiddelen

  • Chapter
  • First Online:
  • 1190 Accesses

Inleiding

De volgende groepen lipideverlagende middelen zijn beschikbaar: statinen, cholesterolabsorptieremmers, galzuurbindende harsen, fibraten en nicotinezuur (zie ook tabel 20.2). De effecten van deze middelen op de serumlipiden en de lipoproteïnen zijn schematisch weergegeven in tabel 20.1.

This is a preview of subscription content, log in via an institution.

Buying options

eBook
USD   24.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatuur

  1. Multidisciplinaire richtlijn Cardiovasculair Risicomanagement 2011. Bohn Stafleu van Loghum ISBN 978-90-313-91769.

    Google Scholar 

  2. ESC/EAS Guidelines for the management of dyslipidemias. European Heart Journal 2011;32:1769-1818.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 2014 Bohn Stafleu van Loghum

About this chapter

Cite this chapter

Graaf, J. (2014). Lipideverlagende geneesmiddelen. In: van Dijkman, P., Bartelink, M., Rubens, M. (eds) Het cardiovasculair formularium. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-9985-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-9985-7_20

  • Published:

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-9984-0

  • Online ISBN: 978-90-313-9985-7

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics